Disability News and Research

RSS

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

7 Mar 2011

Anthem Life sponsors USABA to host Winter Ski Festival for visually impaired athletes

Sponsored by Anthem Life Insurance Company, The United States Association of Blind Athletes is pleased to host the second annual Colorado Winter Ski Festival in Breckenridge, CO, from Friday, March 11 through Monday, March 14.

5 Mar 2011

OHSU receives NTI grant to study TEG for blood-clot prevention in obese trauma patients

Martin Schreiber, M.D., of Oregon Health & Science University, received a research grant worth nearly $700,000 from the National Trauma Institute to study a method that could more accurately determine how much blood-clot prevention medication to give critically ill or obese trauma patients.

5 Mar 2011

Alcohol, marijuana and methamphetamines are common abuse substances

A new study shows that the most commonly abused substances among those 18 and older referred to substance abuse treatment from parole or probation was alcohol, followed by marijuana and methamphetamines.

4 Mar 2011

AAOS releases clinical practice guideline to treat rotator cuff tears

The American Academy of Orthopaedic Surgeons Board of Directors approved and released a clinical practice guideline for treating rotator cuff tears.

4 Mar 2011

CAS is an economically attractive alternative to endarterectomy for stroke patients

Researchers determined that carotid artery stenting with embolic protection is an economically attractive alternative to endarterectomy for patients at increased surgical risk.

3 Mar 2011

Baby frozen to correct brain damage at birth makes full recovery

Baby Ella was born starved of oxygen but doctors cooled her body for three days to reduce brain damage. She made a complete recovery. After birth Ella was wrapped in a special blanket filled with fluid which cooled her whole body down from the normal 37°c to 33.5°c by doctors at Addenbrooke’s Hospital in Cambridge.

3 Mar 2011

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

While lab tests and imaging can sometimes help diagnose juvenile idiopathic arthritis (JIA), a physical examination and thorough patient history are the most valuable tools in identifying this disease. According to a new literature review from the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the rate of false positives in laboratory evaluations and imaging studies meant to screen for juvenile arthritis makes their value limited.

3 Mar 2011

SSLG files Class Action lawsuit against SSA for failure to disclose queried information

The Social Security Law Group, LLP announced today that it has filed a Class Action lawsuit against the Social Security Administration on behalf of its clients after SSA's repeated failures to disclose queried information as required by the Freedom of Information Act and the 1974 Privacy Act.

3 Mar 2011

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Ken Kewley woke up Tuesday without health insurance for the first time in nearly nine years. So did most of the 41,467 other Pennsylvanians who had been covered by adultBasic, a state-subsidized insurance program for the working poor that Gov. Tom Corbett shut down on Monday in one of the largest disenrollments in recent memory.

2 Mar 2011

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company’s proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).

2 Mar 2011

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.

2 Mar 2011

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

EPO to grant patent for Apricus MycoVa product to treat nail fungus

Apricus Biosciences, Inc. announced today that the European Patent Office will grant a patent for the company's MycoVa product for treating onychomycosis.

2 Mar 2011

Bone marrow stem cell transplantation feasible, safe treatment for children with severe traumatic brain injury

For children with severe traumatic brain injury (TBI), transplantation of stem cells derived from the patients' own bone marrow is a "logistically feasible and safe" treatment procedure, reports the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

2 Mar 2011

CIGNA's integrated disability and medical programs reduce workplace absence

Employees who have both disability and medical coverage from CIGNA, and who also suffer a short-term disabling illness or injury, return to work more often and spend less time away from work on leave than those without the integrated program. This is the conclusion of a new study by CIGNA comparing integrated and non-integrated disability and medical plans.

25 Feb 2011

$IOF new report reveals poor status of post-fracture care and osteoporosis management in 21 countries$

Disability News and Research

Prevalence of bipolar disorder

Aerie Pharmaceuticals closes $30 million Series B financing

Anthem Life sponsors USABA to host Winter Ski Festival for visually impaired athletes

OHSU receives NTI grant to study TEG for blood-clot prevention in obese trauma patients

Alcohol, marijuana and methamphetamines are common abuse substances

AAOS releases clinical practice guideline to treat rotator cuff tears

CAS is an economically attractive alternative to endarterectomy for stroke patients

Baby frozen to correct brain damage at birth makes full recovery

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

SSLG files Class Action lawsuit against SSA for failure to disclose queried information

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

EPO to grant patent for Apricus MycoVa product to treat nail fungus

Bone marrow stem cell transplantation feasible, safe treatment for children with severe traumatic brain injury

CIGNA's integrated disability and medical programs reduce workplace absence

IOF new report reveals poor status of post-fracture care and osteoporosis management in 21 countries

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Lux initiates pivotal voclosporin Phase 3 trial in non-infectious uveitis

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News